An explosion of new research is leading to new treatments for neuromuscular disease, according to Dr Janet Woodcock, director of the Center for Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA).
An explosion of new research is leading to new treatments for neuromuscular disease, according to Dr Janet Woodcock, director of the Center for Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA).